We, as clinical research professionals, strive to create and provide reliable healthcare information through our business activities below.
Our SMO collaborates with healthcare institutions to achieve high-quality, accurate clinical trials. We also help healthcare institutions construct an environment which enables them to conduct clinical trials appropriately, by networking healthcare institutions mainly in central Japan.
*Our SMO business has been continuously conducted by Shin Nippon Biomedical Laboratories SMO, Ltd. since January 1, 2018.
Our CR division provides a full range of support such as protocol development, data management and analysis, and manuscript writing on clinical research. Our CR division is working towards making CSS a leading company in measuring study participants' subjective opinions about quality of life (QOL) and patient satisfaction.
CSS believes that conveying reliable, accurate healthcare information to the world is very important. However, in the real world, it is difficult for individuals to acquire accurate, beneficial information from a clutter of information sources of varying quality. IH, our new group of experts handling healthcare information, works on constructing infrastructure to convey accurate healthcare information to the world.